Evidence map›Paper›PMID 34112789›Full record

ArticleNature communications2021

BRCA1 binds TERRA RNA and suppresses R-Loop-based telomeric DNA damage.

Jekaterina Vohhodina, Liana J Goehring, Ben Liu, Qing Kong, Vladimir V Botchkarev, Mai Huynh, Zhiqi Liu, Fieda O Abderazzaq, Allison P Clark, Scott B Ficarro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. G-Quadruplexes: Structural Diversity and Emerging Roles in Biomolecular Condensation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Transcription-Coupled Repair and R-Loop Crosstalk in Genome Stability.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Review
  18. Review
  19. Mechanisms underlining R-loop biology and implications for human disease.Frontiers in cell and developmental biology · 2025
    Review
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jekaterina VohhodinaDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. jekaterina_vohhodina@dfci.harvard.edu.ORCID 0000-0001-8025-5190
Liana J GoehringDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Ben LiuDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Qing KongDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Vladimir V BotchkarevDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Mai HuynhDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Zhiqi LiuDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Fieda O AbderazzaqDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Allison P ClarkDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Scott B FicarroDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jarrod A MartoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0003-2086-1134
Elodie HatchiDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID 0000-0001-8494-9851
David M LivingstonDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. david_livingston@dfci.harvard.edu.ORCID 0000-0001-5765-6025
Harvard University · USDana-Farber Cancer Institute · USBrigham and Women's Hospital · US

Funding

Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of ClonalP01CA080111 · NCI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI DILLON, DEBORAH · 1999 to 2018
$36.0M
BRCA1 Function in Post-Damage Nuclear FociR01CA136512 · NCI · DANA-FARBER CANCER INST · PI LIVINGSTON, DAVID MORSE · 2009 to 2019
$4.6M
Deciphering the mechanism underlying BRCA1 breast cancer developmentR35CA242143 · NCI · DANA-FARBER CANCER INST · PI LIVINGSTON, DAVID MORSE · 2019 to 2021
$3.0M
NCI NIH HHS P01 CA080111NCI NIH HHS R01 CA136512NCI NIH HHS R35 CA242143
6 · The paper itself

Abstract

R-loop structures act as modulators of physiological processes such as transcription termination, gene regulation, and DNA repair. However, they can cause transcription-replication conflicts and give rise to genomic instability, particularly at telomeres, which are prone to forming DNA secondary structures. Here, we demonstrate that BRCA1 binds TERRA RNA, directly and physically via its N-terminal nuclear localization sequence, as well as telomere-specific shelterin proteins in an R-loop-, and a cell cycle-dependent manner. R-loop-driven BRCA1 binding to CpG-rich TERRA promoters represses TERRA transcription, prevents TERRA R-loop-associated damage, and promotes its repair, likely in association with SETX and XRN2. BRCA1 depletion upregulates TERRA expression, leading to overly abundant TERRA R-loops, telomeric replication stress, and signs of telomeric aberrancy. Moreover, BRCA1 mutations within the TERRA-binding region lead to an excess of TERRA-associated R-loops and telomeric abnormalities. Thus, normal BRCA1/TERRA binding suppresses telomere-centered genome instability.

Indexed as

R-Loop StructuresBRCA1 ProteinCell CycleCell Line, TumorChromatin ImmunoprecipitationChromatography, LiquidCpG IslandsDNA DamageDNA HelicasesExoribonucleasesHumansIn Situ Hybridization, FluorescenceMass SpectrometryMultifunctional EnzymesMutationPromoter Regions, GeneticBRCA1 ProteinBRCA1 protein, humanDNA HelicasesExoribonucleasesMultifunctional EnzymesRNA HelicasesRNA, Long NoncodingRNA, Small InterferingSETX protein, humanXRN2 protein, human

Identifiers

PMID34112789
PMCPMC8192922
OpenAlexW3169853102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.